Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novo Nordisk A/S ADR
(NY:
NVO
)
135.42
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novo Nordisk A/S ADR
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
51
52
Next >
Is This a Dead-Cat Bounce? 3 Must-Buy Stocks Just in Case.
September 13, 2023
History suggests the market is ready to run higher, but it could also be a false positive that results in a dead-cat bounce.
Via
InvestorPlace
Should You Buy NVO Stock Ahead of the Novo Nordisk Stock Split?
September 13, 2023
Ozempic producer Novo Nordisk is about to split its stock again. Here's why investors should be watching NVO stock closely.
Via
InvestorPlace
This Is What Whales Are Betting On Novo Nordisk
September 13, 2023
Via
Benzinga
Madrigal Pharmaceuticals Surges As Its NASH Treatment Toes The Long-Awaited Finish Line
September 13, 2023
The company is toeing the finish line with a NASH treatment, an area of medicine marked by failures.
Via
Investor's Business Daily
Why Is Eiger BioPharmaceuticals (EIGR) Stock Down 31% Today?
September 13, 2023
Eiger BioPharmaceuticals (EIGR) stock is falling on Wednesday after the biopharmaceutical company halted a Phase 3 clinical trial.
Via
InvestorPlace
Why Is Calidi Biotherapeutics (CLDI) Stock Down 36% Today?
September 13, 2023
Calidi Biotherapeutics (CLDI) stock is taking a beating on Wednesday following the clinical-stage biotechnology company's public debut.
Via
InvestorPlace
(NVO) - Analyzing Novo Nordisk's Short Interest
September 11, 2023
Via
Benzinga
1 Stock Split Stock to Buy Hand Over Fist Right Now
September 08, 2023
Novo Nordisk stock is up nearly 40% so far in 2023. But it could be headed even higher in short order.
Via
The Motley Fool
Is Novo Nordisk Stock a Buy Now?
September 07, 2023
Novo Nordisk recently launched Wegovy in the United Kingdom.
Via
The Motley Fool
Why Is Avalo Therapeutics (AVTX) Stock Up 69% Today?
September 13, 2023
Avalo Therapeutics (AVTX) stock is taking off on Wednesday after the biotechnology company announced a $45 million asset sale.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
September 13, 2023
It's time for another dive into the biggest pre-market stock movers as we check out all the shares worth watching on Wednesday!
Via
InvestorPlace
Wall Street Has Found Its Next High-Flying Stock-Split Stock. Here's Why I'm Not Buying the Hype.
September 12, 2023
Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, and Monster Beverage have all split their shares since July 2021. Next week, another industry leader will join this exclusive...
Via
The Motley Fool
Pound for Pound: 3 Buzzworthy Drug Stocks Worth Their Weight in Gold
September 11, 2023
Investors looking for exposure to a booming business should hitch their wagons to one of these leading pharmaceutical companies.
Via
InvestorPlace
Novo Nordisk Unusual Options Activity
September 06, 2023
Via
Benzinga
Novo Nordisk Rolls Out Its Weight Loss Drug Wegovy In The UK
September 04, 2023
Weekly injection will initially be available via NHS only to limited patients.
Via
Talk Markets
Novo Nordisk Reacted Higher From Support Area
September 10, 2023
Novo Nordisk, a healthcare company engages in the research, development, manufacture & marketing of the pharmaceutical products worldwide. It is based in Denmark, comes under Healthcare – Biotechnology...
Via
Talk Markets
Investors May Not Have Seen the Best From Eli Lilly Stock Yet. Here's Why.
September 10, 2023
Mounjaro has been on the market for roughly one year and is already generating billions in sales for Eli Lilly. But with that said, its best days could be ahead.
Via
The Motley Fool
3 Top Healthcare Stocks to Buy for September
September 09, 2023
These blue-chip healthcare stocks are trading at attractive valuations today.
Via
The Motley Fool
UK Authority Recommends Eli Lilly's Famed Diabetes Drug Mounjaro As New Treatment Option For Type 2 Diabetes
September 08, 2023
UK's National Institute for Health and Care Excellence (NICE) has endorsed Eli Lilly And Co's (NYSE: LLY) diabetes medication, Mounjaro (tirzepatide), indicating it as a viable option for patients...
Via
Benzinga
The 3 Best Stocks to Buy Now: September 2023
September 07, 2023
These three best stocks to buy now are the worthwhile investments in this month due to long term growth and sustained profitability.
Via
InvestorPlace
Why Novo Nordisk Stock Topped the Market on Thursday
September 07, 2023
The company behind Wegovy got a bullish boost from a top group of prognosticators.
Via
The Motley Fool
Novo Nordisk Is Already Working on Ozempic 2.0. Here's How to Profit
September 07, 2023
The next version of this blockbuster drug won't be ready for a while, but it'll likely be a big earner.
Via
The Motley Fool
3 Nasdaq Stocks to Sell in September Before They Crash & Burn
September 07, 2023
These Nasdaq stocks to sell are all risky plays with uncertain futures. It's a good idea to sell or trim your positions in them now.
Via
InvestorPlace
Popular Obesity Drugs For Dementia, Addiction Treatment? Researchers Explore Potential
September 07, 2023
Scientists are now exploring the potential of popular obesity drugs to address conditions like dementia and alcohol addiction, following recent trials that demonstrated the drugs' effectiveness in...
Via
Benzinga
7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth
September 07, 2023
Finding the best pharma stocks to buy takes a little effort, but it will pay of with these seven long-term winners.
Via
InvestorPlace
Facebook News To Shut Down In Europe, Warner Bros. Discovery Revises Outlook As Strike Bites, Manchester United No Longer Up For Sale: Today's Top Stories
September 05, 2023
Benzinga Why Facebook News is Shutting Down in Europe: What It Means for Users?
Via
Benzinga
Novo Nordisk's Weight Loss Drug Wegovy In Short Supply, Yet Goes Ahead With UK Launch
September 05, 2023
On Monday, Novo Nordisk A/S (NYSE: NVO)
Via
Benzinga
China Rallies, Europe Dips: US Market Outlook For Labor Day-Shortened Week
September 04, 2023
Via
Benzinga
Ozempic Maker Beats Bernard Arnault's LVMH As Europe's Most Valuable Firm With Stunning $423B Market Cap
September 04, 2023
Ozempic, Wegovy maker Novo Nordisk is Europe's most-valued company, going past the market cap of LVMH, run by the world's 2nd richest man.
Via
Benzinga
Could CVS Make a Copy of Ozempic?
September 02, 2023
Given its new biosimilars unit, copying Ozempic is more likely than it sounds.
Via
The Motley Fool
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
51
52
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.